ADME 101: Microsomal Protein Binding of Drugs
Presenter: Kusum Parikh, MBBS, PhD, XenoTech Senior Scientist in Program Oversight
Abstract:
Regulatory guidance states that drug developers should correct for nonspecific binding in microsomes if it is expected to influence the analysis of kinetic data. Evaluating microsomal protein binding provides a better understanding of the relationship between in vitro metabolism and in vivo pharmacokinetics. Since this data provides insight into how the drug may be distributed throughout and cleared by the body, it is important for developing the DMPK profile as well as assessing the drug-drug interaction potential of a drug candidate.
Key concepts discussed in this webinar will include:
- What is microsomal protein binding (MPB)?
- Why is measuring MPB important?
- Methods to measure MPB
- MPB study design
- Sample data
About the Presenter:
Dr. Kusum Parikh is a Senior Scientist in the Program Oversight division serving as a Study Director for enzyme inhibition, enzyme induction, plasma protein binding and microsomal protein binding studies. Kusum earned her MBBS degree from Seth Gordhandas Sunderdas Medical College and the King Edward Memorial (KEM) Hospital, Mumbai, India. She subsequently obtained her Ph.D. in Human Genetics at University of Pittsburgh which was followed by her postdoctoral training in the Department of Medicine at University of Pittsburgh. During the course of her training, Kusum has published several original research articles, contributed to book chapters and was an invited speaker in scientific conferences.